N-Methyl-N-[6-methyl-4-(trifluoromethyl)pyridin-2-yl]glycine, 95.0%, 1g

Dialysis membrane Spectra/Por® 6 MWCO 15,000, 32 mm, 1 Piece(s)

Methyl 2-(3-bromophenyl)acetate, 95.0%, 100g

Niobium(V) oxide pieces 99.99% 1-4 mm 100 g

(2R,3R,4R,5S,6R)-2-phenethoxy-6-((((3R,4R,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methoxy)methyl)tetrahydro-2H-pyran-3,4,5-triol, 98%, 25mg

3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97.0%, 5g

3-TERT-BUTOXYCARBONYLAMINO-CYCLOBUTANE-1,1-DICARBOXYLIC ACID DIISOPROPYL ESTER, 95.0%, 250mg

2-Chloro-1,1,1,3,4,4,4-heptafluorobutane, 98.0%, 1g

Tetrabutylammonium cyanide, 95.0%, 25g

Sodium salicylate 99.5+% 1 g

2-Chloro-6-fluoroquinazolin-4(3H)-one, 95.0%, 250mg

Triethylene Glycol Dimethacrylate (stabilized with MEHQ)>95.0%(GC)25mL

1,3-dimethylbarbituric acid, min. 98%, for synthesis, 250 g, plastic packaging.